Global Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Publisher Name :
Date: 16-Aug-2021
No. of pages: 125
Inquire Before Buying

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Global Heparin key players include Hepalink, Bioibérica, Pfizer, King-friend Biochemical Pharmaceutical, Jiulong Biochemicals, etc. Global top five manufacturers hold a share about 55%. Europe is the largest market, with a share about 40%, followed by USA, with a share about 35 percent. In terms of product, Heparin Sodium is the largest segment, with a share about 90%. And in terms of application, the largest application is LMWH, followed by UFH.

Market Analysis and Insights: Global Heparin Market

In 2020, the global Heparin market size was US$ 1087 million and it is expected to reach US$ 1332.1 million by the end of 2027, with a CAGR of 3.4% during 2021-2027.

Global Heparin Scope and Market Size

Heparin market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the Heparin market is segmented into

- Heparin Sodium

- Heparin Calcium

- Other

Segment by Application, the Heparin market is segmented into

- UFH

- LMWH

Regional and Country-level Analysis:

- North America

- - United States

- - Canada

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Competitive Landscape and Heparin Market Share Analysis

Heparin market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Heparin product introduction, recent developments, Heparin sales by region, type, application and by sales channel.

The major companies include:

- Hepalink

- Changshan Pharm

- Qianhong Bio-pharma

- Opocrin

- Pfizer

- Aspen Oss

- King-friend Biochemical Pharmaceutical

- Bioibérica

- Dongcheng Biochemicals

- Jiulong Biochemicals

- Tiandong

- Xinbai

- Yino Pharma

- Deebio

Global Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Table of Contents
1 Study Coverage
1.1 Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Heparin Market Size Growth Rate by Type
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.2.4 Other
1.3 Market by Application
1.3.1 Global Heparin Market Size Growth Rate by Application
1.3.2 UFH
1.3.3 LMWH
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heparin Market Size Estimates and Forecasts
2.1.1 Global Heparin Revenue 2016-2027
2.1.2 Global Heparin Sales 2016-2027
2.2 Heparin Market Size by Region: 2021 Versus 2027
2.3 Heparin Sales by Region (2016-2027)
2.3.1 Global Heparin Sales by Region: 2016-2021
2.3.2 Global Heparin Sales Forecast by Region (2022-2027)
2.3.3 Global Heparin Sales Market Share by Region (2016-2027)
2.4 Heparin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Heparin Revenue by Region: 2016-2021
2.4.2 Global Heparin Revenue Forecast by Region (2022-2027)
2.4.3 Global Heparin Revenue Market Share by Region (2016-2027)
3 Global Heparin by Manufacturers
3.1 Global Top Heparin Manufacturers by Sales
3.1.1 Global Heparin Sales by Manufacturer (2016-2021)
3.1.2 Global Heparin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Heparin Manufacturers by Revenue
3.2.1 Global Heparin Revenue by Manufacturer (2016-2021)
3.2.2 Global Heparin Revenue Share by Manufacturer (2016-2021)
3.3 Global Heparin Price by Manufacturer (2016-2021)
3.4 Competitive Landscape
3.4.1 Key Heparin Manufacturers Covered: Ranking by Revenue
3.4.2 Global Heparin Market Concentration Ratio (CR5 and HHI) & (2016-2021)
3.4.3 Global Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Heparin Manufacturing Base Distribution, Product Type
3.5.1 Heparin Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Heparin Product Type
3.5.3 Date of International Manufacturers Enter into Heparin Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Hepalink
4.1.1 Hepalink Corporation Information
4.1.2 Hepalink Description, Business Overview
4.1.3 Hepalink Heparin Products Offered
4.1.4 Hepalink Heparin Sales, Revenue and Gross Margin (2016-2021)
4.1.5 Hepalink Heparin Revenue by Product
4.1.6 Hepalink Heparin Revenue by Application
4.1.7 Hepalink Heparin Revenue by Geographic Area
4.1.8 Hepalink Heparin Revenue by Sales Channel
4.1.9 Hepalink Recent Development
4.2 Changshan Pharm
4.2.1 Changshan Pharm Corporation Information
4.2.2 Changshan Pharm Description, Business Overview
4.2.3 Changshan Pharm Heparin Products Offered
4.2.4 Changshan Pharm Heparin Sales, Revenue and Gross Margin (2016-2021)
4.2.5 Changshan Pharm Heparin Revenue by Product
4.2.6 Changshan Pharm Heparin Revenue by Application
4.2.7 Changshan Pharm Heparin Revenue by Geographic Area
4.2.8 Changshan Pharm Heparin Revenue by Sales Channel
4.2.9 Changshan Pharm Recent Development
4.3 Qianhong Bio-pharma
4.3.1 Qianhong Bio-pharma Corporation Information
4.3.2 Qianhong Bio-pharma Description, Business Overview
4.3.3 Qianhong Bio-pharma Heparin Products Offered
4.3.4 Qianhong Bio-pharma Heparin Sales, Revenue and Gross Margin (2016-2021)
4.3.5 Qianhong Bio-pharma Heparin Revenue by Product
4.3.6 Qianhong Bio-pharma Heparin Revenue by Application
4.3.7 Qianhong Bio-pharma Heparin Revenue by Geographic Area
4.3.8 Qianhong Bio-pharma Heparin Revenue by Sales Channel
4.3.9 Qianhong Bio-pharma Recent Development
4.4 Opocrin
4.4.1 Opocrin Corporation Information
4.4.2 Opocrin Description, Business Overview
4.4.3 Opocrin Heparin Products Offered
4.4.4 Opocrin Heparin Sales, Revenue and Gross Margin (2016-2021)
4.4.5 Opocrin Heparin Revenue by Product
4.4.6 Opocrin Heparin Revenue by Application
4.4.7 Opocrin Heparin Revenue by Geographic Area
4.4.8 Opocrin Heparin Revenue by Sales Channel
4.4.9 Opocrin Recent Development
4.5 Pfizer
4.5.1 Pfizer Corporation Information
4.5.2 Pfizer Description, Business Overview
4.5.3 Pfizer Heparin Products Offered
4.5.4 Pfizer Heparin Sales, Revenue and Gross Margin (2016-2021)
4.5.5 Pfizer Heparin Revenue by Product
4.5.6 Pfizer Heparin Revenue by Application
4.5.7 Pfizer Heparin Revenue by Geographic Area
4.5.8 Pfizer Heparin Revenue by Sales Channel
4.5.9 Pfizer Recent Development
4.6 Aspen Oss
4.6.1 Aspen Oss Corporation Information
4.6.2 Aspen Oss Description, Business Overview
4.6.3 Aspen Oss Heparin Products Offered
4.6.4 Aspen Oss Heparin Sales, Revenue and Gross Margin (2016-2021)
4.6.5 Aspen Oss Heparin Revenue by Product
4.6.6 Aspen Oss Heparin Revenue by Application
4.6.7 Aspen Oss Heparin Revenue by Geographic Area
4.6.8 Aspen Oss Recent Development
4.7 King-friend Biochemical Pharmaceutical
4.7.1 King-friend Biochemical Pharmaceutical Corporation Information
4.7.2 King-friend Biochemical Pharmaceutical Description, Business Overview
4.7.3 King-friend Biochemical Pharmaceutical Heparin Products Offered
4.7.4 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2016-2021)
4.7.5 King-friend Biochemical Pharmaceutical Heparin Revenue by Product
4.7.6 King-friend Biochemical Pharmaceutical Heparin Revenue by Application
4.7.7 King-friend Biochemical Pharmaceutical Heparin Revenue by Geographic Area
4.7.8 King-friend Biochemical Pharmaceutical Recent Development
4.8 Bioibérica
4.8.1 Bioibérica Corporation Information
4.8.2 Bioibérica Description, Business Overview
4.8.3 Bioibérica Heparin Products Offered
4.8.4 Bioibérica Heparin Sales, Revenue and Gross Margin (2016-2021)
4.8.5 Bioibérica Heparin Revenue by Product
4.8.6 Bioibérica Heparin Revenue by Application
4.8.7 Bioibérica Heparin Revenue by Geographic Area
4.8.8 Bioibérica Recent Development
4.9 Dongcheng Biochemicals
4.9.1 Dongcheng Biochemicals Corporation Information
4.9.2 Dongcheng Biochemicals Description, Business Overview
4.9.3 Dongcheng Biochemicals Heparin Products Offered
4.9.4 Dongcheng Biochemicals Heparin Sales, Revenue and Gross Margin (2016-2021)
4.9.5 Dongcheng Biochemicals Heparin Revenue by Product
4.9.6 Dongcheng Biochemicals Heparin Revenue by Application
4.9.7 Dongcheng Biochemicals Heparin Revenue by Geographic Area
4.9.8 Dongcheng Biochemicals Recent Development
4.10 Jiulong Biochemicals
4.10.1 Jiulong Biochemicals Corporation Information
4.10.2 Jiulong Biochemicals Description, Business Overview
4.10.3 Jiulong Biochemicals Heparin Products Offered
4.10.4 Jiulong Biochemicals Heparin Sales, Revenue and Gross Margin (2016-2021)
4.10.5 Jiulong Biochemicals Heparin Revenue by Product
4.10.6 Jiulong Biochemicals Heparin Revenue by Application
4.10.7 Jiulong Biochemicals Heparin Revenue by Geographic Area
4.10.8 Jiulong Biochemicals Recent Development
4.11 Tiandong
4.11.1 Tiandong Corporation Information
4.11.2 Tiandong Description, Business Overview
4.11.3 Tiandong Heparin Products Offered
4.11.4 Tiandong Heparin Sales, Revenue and Gross Margin (2016-2021)
4.11.5 Tiandong Heparin Revenue by Product
4.11.6 Tiandong Heparin Revenue by Application
4.11.7 Tiandong Heparin Revenue by Geographic Area
4.11.8 Tiandong Recent Development
4.12 Xinbai
4.12.1 Xinbai Corporation Information
4.12.2 Xinbai Description, Business Overview
4.12.3 Xinbai Heparin Products Offered
4.12.4 Xinbai Heparin Sales, Revenue and Gross Margin (2016-2021)
4.12.5 Xinbai Heparin Revenue by Product
4.12.6 Xinbai Heparin Revenue by Application
4.12.7 Xinbai Heparin Revenue by Geographic Area
4.12.8 Xinbai Recent Development
4.13 Yino Pharma
4.13.1 Yino Pharma Corporation Information
4.13.2 Yino Pharma Description, Business Overview
4.13.3 Yino Pharma Heparin Products Offered
4.13.4 Yino Pharma Heparin Sales, Revenue and Gross Margin (2016-2021)
4.13.5 Yino Pharma Heparin Revenue by Product
4.13.6 Yino Pharma Heparin Revenue by Application
4.13.7 Yino Pharma Heparin Revenue by Geographic Area
4.13.8 Yino Pharma Recent Development
4.14 Deebio
4.14.1 Deebio Corporation Information
4.14.2 Deebio Description, Business Overview
4.14.3 Deebio Heparin Products Offered
4.14.4 Deebio Heparin Sales, Revenue and Gross Margin (2016-2021)
4.14.5 Deebio Heparin Revenue by Product
4.14.6 Deebio Heparin Revenue by Application
4.14.7 Deebio Heparin Revenue by Geographic Area
4.14.8 Deebio Recent Development
5 Breakdown Data by Type
5.1 Global Heparin Sales by Type (2016-2027)
5.1.1 Global Heparin Sales by Type (2016-2021)
5.1.2 Global Heparin Sales Forecast by Type (2022-2027)
5.1.3 Global Heparin Sales Market Share by Type (2016-2027)
5.2 Global Heparin Revenue Forecast by Type (2016-2027)
5.2.1 Global Heparin Revenue by Type (2016-2021)
5.2.2 Global Heparin Revenue Forecast by Type (2022-2027)
5.2.3 Global Heparin Revenue Market Share by Type (2016-2027)
5.3 Heparin Average Selling Price (ASP) by Type (2016-2027)
6 Breakdown Data by Application
6.1 Global Heparin Sales by Application (2016-2027)
6.1.1 Global Heparin Sales by Application (2016-2021)
6.1.2 Global Heparin Sales Forecast by Application (2022-2027)
6.1.3 Global Heparin Sales Market Share by Application (2016-2027)
6.2 Global Heparin Revenue Forecast by Application (2016-2027)
6.2.1 Global Heparin Revenue by Application (2016-2021)
6.2.2 Global Heparin Revenue Forecast by Application (2022-2027)
6.2.3 Global Heparin Revenue Market Share by Application (2016-2027)
6.3 Heparin Average Selling Price (ASP) by Application (2016-2027)
7 North America
7.1 North America Heparin Market Size YoY Growth 2016-2027
7.2 North America Heparin Market Facts & Figures by Country
7.2.1 North America Heparin Sales by Country (2016-2027)
7.2.2 North America Heparin Revenue by Country (2016-2027)
7.3 North America Heparin Sales by Type
7.4 North America Heparin Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Heparin Market Size YoY Growth 2016-2027
8.2 Asia-Pacific Heparin Market Facts & Figures by Region
8.2.1 Asia-Pacific Heparin Sales by Region (2016-2027)
8.2.2 Asia-Pacific Heparin Revenue by Region (2016-2027)
8.3 Asia-Pacific Heparin Sales by Type
8.4 Asia-Pacific Heparin Sales by Application
9 Europe
9.1 Europe Heparin Market Size YoY Growth 2016-2027
9.2 Europe Heparin Market Facts & Figures by Country
9.2.1 Europe Heparin Sales by Country (2016-2027)
9.2.2 Europe Heparin Revenue by Country (2016-2027)
9.3 Europe Heparin Sales by Type
9.4 Europe Heparin Sales by Application
10 Latin America
10.1 Latin America Heparin Market Size YoY Growth 2016-2027
10.2 Latin America Heparin Market Facts & Figures by Country
10.2.1 Latin America Heparin Sales by Country (2016-2027)
10.2.2 Latin America Heparin Revenue by Country (2016-2027)
10.3 Latin America Heparin Sales by Type
10.4 Latin America Heparin Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Heparin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Heparin Market Facts & Figures by Country
11.2.1 Middle East and Africa Heparin Sales by Country (2016-2027)
11.2.2 Middle East and Africa Heparin Revenue by Country (2016-2027)
11.3 Middle East and Africa Heparin Sales by Type
11.4 Middle East and Africa Heparin Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Heparin Supply Chain Analysis
12.2 Heparin Key Raw Materials and Upstream Suppliers
12.3 Heparin Clients Analysis
12.4 Heparin Sales Channel and Sales Model Analysis
12.4.1 Heparin Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Heparin Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Heparin Distributors
13 Market Dynamics
13.1 Heparin Market Drivers
13.2 Heparin Market Opportunities
13.3 Heparin Market Challenges
13.4 Heparin Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Heparin Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Major Manufacturers of Heparin Sodium
Table 3. Major Manufacturers of Heparin Calcium
Table 4. Major Manufacturers of Other
Table 5. Global Heparin Market Size Growth by Application (US$ Million): 2021 VS 2027
Table 6. Global Heparin Market Size by Region (US$ Million): 2021 VS 2027
Table 7. Global Heparin Sales by Region (2016-2021) & (B Units)
Table 8. Global Heparin Sales Forecast by Region (2022-2027) & (B Units)
Table 9. Global Heparin Revenue by Region (2016-2021) & (US$ Million)
Table 10. Global Heparin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 11. Global Heparin Sales by Manufacturer (2016-2021) & (B Units)
Table 12. Global Heparin Sales Share by Manufacturer (2016-2021)
Table 13. Heparin Revenue by Manufacturer (2016-2021) & (US$ Million)
Table 14. Heparin Revenue Share by Manufacturer (2016-2021)
Table 15. Key Manufacturers Heparin Price (2016-2021) & (USD/Unit)
Table 16. Ranking of Global Top Heparin Manufacturers by Revenue (US$ Million) in 2020
Table 17. Global Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 18. Global Heparin by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Heparin as of 2020)
Table 19. Heparin Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Heparin Product Type
Table 21. Date of International Manufacturers Enter into Heparin Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Hepalink Corporation Information
Table 24. Hepalink Description and Business Overview
Table 25. Hepalink Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 26. Hepalink Heparin Product
Table 27. Hepalink Heparin Revenue (US$ Million) and Market Share by Product
Table 28. Hepalink Heparin Revenue (US$ Million) and Market Share by Application
Table 29. Hepalink Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 30. Hepalink Heparin Revenue (US$ Million) and Market Share by Sales Channel
Table 31. Hepalink Recent Development
Table 32. Changshan Pharm Corporation Information
Table 33. Changshan Pharm Description and Business Overview
Table 34. Changshan Pharm Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 35. Changshan Pharm Heparin Product
Table 36. Changshan Pharm Heparin Revenue (US$ Million) and Market Share by Product
Table 37. Changshan Pharm Heparin Revenue (US$ Million) and Market Share by Application
Table 38. Changshan Pharm Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 39. Changshan Pharm Heparin Revenue (US$ Million) and Market Share by Sales Channel
Table 40. Changshan Pharm Recent Development
Table 41. Qianhong Bio-pharma Corporation Information
Table 42. Qianhong Bio-pharma Description and Business Overview
Table 43. Qianhong Bio-pharma Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 44. Qianhong Bio-pharma Heparin Product
Table 45. Qianhong Bio-pharma Heparin Revenue (US$ Million) and Market Share by Product
Table 46. Qianhong Bio-pharma Heparin Revenue (US$ Million) and Market Share by Application
Table 47. Qianhong Bio-pharma Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 48. Qianhong Bio-pharma Heparin Revenue (US$ Million) and Market Share by Sales Channel
Table 49. Qianhong Bio-pharma Recent Development
Table 50. Opocrin Corporation Information
Table 51. Opocrin Description and Business Overview
Table 52. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 53. Opocrin Heparin Product
Table 54. Opocrin Heparin Revenue (US$ Million) and Market Share by Product
Table 55. Opocrin Heparin Revenue (US$ Million) and Market Share by Application
Table 56. Opocrin Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 57. Opocrin Heparin Revenue (US$ Million) and Market Share by Sales Channel
Table 58. Opocrin Recent Development
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 62. Pfizer Heparin Product
Table 63. Pfizer Heparin Revenue (US$ Million) and Market Share by Product
Table 64. Pfizer Heparin Revenue (US$ Million) and Market Share by Application
Table 65. Pfizer Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 66. Pfizer Heparin Revenue (US$ Million) and Market Share by Sales Channel
Table 67. Pfizer Recent Development
Table 68. Aspen Oss Corporation Information
Table 69. Aspen Oss Description and Business Overview
Table 70. Aspen Oss Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Aspen Oss Heparin Product
Table 72. Aspen Oss Heparin Revenue (US$ Million) and Market Share by Product
Table 73. Aspen Oss Heparin Revenue (US$ Million) and Market Share by Application
Table 74. Aspen Oss Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 75. Aspen Oss Recent Development
Table 76. King-friend Biochemical Pharmaceutical Corporation Information
Table 77. King-friend Biochemical Pharmaceutical Description and Business Overview
Table 78. King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 79. King-friend Biochemical Pharmaceutical Heparin Product
Table 80. King-friend Biochemical Pharmaceutical Heparin Revenue (US$ Million) and Market Share by Product
Table 81. King-friend Biochemical Pharmaceutical Heparin Revenue (US$ Million) and Market Share by Application
Table 82. King-friend Biochemical Pharmaceutical Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 83. King-friend Biochemical Pharmaceutical Recent Development
Table 84. Bioibérica Corporation Information
Table 85. Bioibérica Description and Business Overview
Table 86. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 87. Bioibérica Heparin Product
Table 88. Bioibérica Heparin Revenue (US$ Million) and Market Share by Product
Table 89. Bioibérica Heparin Revenue (US$ Million) and Market Share by Application
Table 90. Bioibérica Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 91. Bioibérica Recent Development
Table 92. Dongcheng Biochemicals Corporation Information
Table 93. Dongcheng Biochemicals Description and Business Overview
Table 94. Dongcheng Biochemicals Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Dongcheng Biochemicals Heparin Product
Table 96. Dongcheng Biochemicals Heparin Revenue (US$ Million) and Market Share by Product
Table 97. Dongcheng Biochemicals Heparin Revenue (US$ Million) and Market Share by Application
Table 98. Dongcheng Biochemicals Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 99. Dongcheng Biochemicals Recent Development
Table 100. Jiulong Biochemicals Corporation Information
Table 101. Jiulong Biochemicals Description and Business Overview
Table 102. Jiulong Biochemicals Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 103. Jiulong Biochemicals Heparin Product
Table 104. Jiulong Biochemicals Heparin Revenue (US$ Million) and Market Share by Product
Table 105. Jiulong Biochemicals Heparin Revenue (US$ Million) and Market Share by Application
Table 106. Jiulong Biochemicals Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 107. Jiulong Biochemicals Recent Development
Table 108. Tiandong Corporation Information
Table 109. Tiandong Description and Business Overview
Table 110. Tiandong Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Tiandong Heparin Product
Table 112. Tiandong Heparin Revenue (US$ Million) and Market Share by Product
Table 113. Tiandong Heparin Revenue (US$ Million) and Market Share by Application
Table 114. Tiandong Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 115. Tiandong Recent Development
Table 116. Xinbai Corporation Information
Table 117. Xinbai Description and Business Overview
Table 118. Xinbai Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 119. Xinbai Heparin Product
Table 120. Xinbai Heparin Revenue (US$ Million) and Market Share by Product
Table 121. Xinbai Heparin Revenue (US$ Million) and Market Share by Application
Table 122. Xinbai Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 123. Xinbai Recent Development
Table 124. Yino Pharma Corporation Information
Table 125. Yino Pharma Description and Business Overview
Table 126. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 127. Yino Pharma Heparin Product
Table 128. Yino Pharma Heparin Revenue (US$ Million) and Market Share by Product
Table 129. Yino Pharma Heparin Revenue (US$ Million) and Market Share by Application
Table 130. Yino Pharma Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 131. Yino Pharma Recent Development
Table 132. Deebio Corporation Information
Table 133. Deebio Description and Business Overview
Table 134. Deebio Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 135. Deebio Heparin Product
Table 136. Deebio Heparin Revenue (US$ Million) and Market Share by Product
Table 137. Deebio Heparin Revenue (US$ Million) and Market Share by Application
Table 138. Deebio Heparin Revenue (US$ Million) and Market Share by Geographic Area
Table 139. Deebio Recent Development
Table 140. Global Heparin Sales by Type (2016-2021) & (B Units)
Table 141. Global Heparin Sales Forecast by Type (2022-2027) & (B Units)
Table 142. Global Heparin Revenue by Type (2016-2021) & (US$ Million)
Table 143. Global Heparin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 144. Global Heparin Sales by Application (2016-2021) & (B Units)
Table 145. Global Heparin Sales Forecast by Application (2022-2027) & (B Units)
Table 146. Global Heparin Revenue by Application (2016-2021) & (US$ Million)
Table 147. Global Heparin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 148. North America Heparin Sales by Country (2016-2021) & (B Units)
Table 149. North America Heparin Sales by Country (2022-2027) & (B Units)
Table 150. North America Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 151. North America Heparin Revenue by Country (2022-2027) & (US$ Million)
Table 152. North America Heparin Sales by Type (2016-2021) & (B Units)
Table 153. North America Heparin Sales by Application (2016-2021) & (B Units)
Table 154. Asia-Pacific Heparin Sales by Region (2016-2021) & (B Units)
Table 155. Asia-Pacific Heparin Sales by Region (2022-2027) & (B Units)
Table 156. Asia-Pacific Heparin Revenue by Region (2016-2027) & (US$ Million)
Table 157. Asia-Pacific Heparin Revenue by Region (2022-2027) & (US$ Million)
Table 158. Asia-Pacific Heparin Sales by Type (2016-2021) & (B Units)
Table 159. Asia-Pacific Heparin Sales by Application (2016-2021) & (B Units)
Table 160. Europe Heparin Sales by Country (2016-2021) & (B Units)
Table 161. Europe Heparin Sales by Country (2022-2027) & (B Units)
Table 162. Europe Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 163. Europe Heparin Revenue by Country (2022-2027) & (US$ Million)
Table 164. Europe Heparin Sales by Type (2016-2021) & (B Units)
Table 165. Europe Heparin Sales by Application (2016-2021) & (B Units)
Table 166. Latin America Heparin Sales by Country (2016-2021) & (B Units)
Table 167. Latin America Heparin Sales by Country (2022-2027) & (B Units)
Table 168. Latin America Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 169. Latin America Heparin Revenue by Country (2022-2027) & (US$ Million)
Table 170. Latin America Heparin Sales by Type (2016-2021) & (B Units)
Table 171. Latin America Heparin Sales by Application (2016-2021) & (B Units)
Table 172. Middle East and Africa Heparin Sales by Country (2016-2021) & (B Units)
Table 173. Middle East and Africa Heparin Sales by Country (2022-2027) & (B Units)
Table 174. Middle East and Africa Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 175. Middle East and Africa Heparin Revenue by Country (2022-2027) & (US$ Million)
Table 176. Middle East and Africa Heparin Sales by Type (2016-2021) & (B Units)
Table 177. Middle East and Africa Heparin Sales by Application (2016-2021) & (B Units)
Table 178. Heparin Key Raw Materials, Industry Status and Trend
Table 179. Heparin Key Raw Materials and Upstream Suppliers
Table 180. Heparin Clients Status and Trend
Table 181. Heparin Typical Clients
Table 182. Heparin Distributors
Table 183. Key Drivers: Impact Analysis (2022-2027)
Table 184. Heparin Market Drivers
Table 185. Heparin Market Opportunities
Table 186. Heparin Market Challenges
Table 187. Heparin Market Restraints
Table 188. Heparin Porter's Five Forces Analysis
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Sales Market Share by Type in 2021 & 2027
Figure 3. Heparin Sodium Product Picture
Figure 4. Heparin Calcium Product Picture
Figure 5. Other Product Picture
Figure 6. Global Heparin Sales Market Share by Application in 2021 & 2027
Figure 7. UFH Examples
Figure 8. LMWH Examples
Figure 9. Heparin Report Years Considered
Figure 10. Global Heparin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Heparin Market Size 2016-2027 (US$ Million)
Figure 12. Global Heparin Sales 2016-2027 (K Units)
Figure 13. Global Heparin Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Heparin Sales Market Share Forecast by Region (2016-2027)
Figure 15. Global Heparin Revenue Market Share by Region (2016-2027)
Figure 16. Global Heparin Sales Share by Manufacturer in 2020
Figure 17. Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 18. Global Heparin Sales Market Share Forecast by Type (2016-2027)
Figure 19. Global Heparin Revenue Market Share Forecast by Type (2016-2027)
Figure 20. Heparin Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Figure 21. Global Heparin Sales Market Share Forecast by Application (2016-2027)
Figure 22. Global Heparin Revenue Market Share Forecast by Application (2016-2027)
Figure 23. Heparin Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Figure 24. North America Heparin Revenue 2016-2027 (US$ Million)
Figure 25. North America Heparin Sales Market Share by Type (2016-2021)
Figure 26. North America Heparin Sales Market Share by Application (2016-2021)
Figure 27. Asia-Pacific Heparin Revenue 2016-2027 (US$ Million)
Figure 28. Asia-Pacific Heparin Sales Market Share by Region (2016-2027)
Figure 29. Asia-Pacific Heparin Revenue Market Share by Region (2016-2027)
Figure 30. Asia-Pacific Heparin Sales Market Share by Type (2016-2021)
Figure 31. Asia-Pacific Heparin Sales Market Share by Application (2016-2021)
Figure 32. Europe Heparin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. Europe Heparin Sales Market Share by Country (2016-2027)
Figure 34. Europe Heparin Revenue Market Share by Country (2016-2027)
Figure 35. Europe Heparin Sales Market Share by Type (2016-2021)
Figure 36. Europe Heparin Sales Market Share by Application (2016-2021)
Figure 37. Latin America Heparin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 38. Latin America Heparin Sales Market Share by Country (2016-2027)
Figure 39. Latin America Heparin Revenue Market Share by Country (2016-2021)
Figure 40. Latin America Heparin Sales Market Share by Type (2016-2021)
Figure 41. Latin America Heparin Sales Market Share by Application (2016-2021)
Figure 42. Middle East and Africa Heparin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 43. Middle East and Africa Heparin Sales Market Share by Country (2016-2027)
Figure 44. Middle East and Africa Heparin Revenue Market Share by Country (2016-2027)
Figure 45. Middle East and Africa Heparin Sales Market Share by Type (2016-2021)
Figure 46. Middle East and Africa Heparin Sales Market Share by Application (2016-2021)
Figure 47. Heparin Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Heparin Raw Materials by Region in 2020
Figure 49. Heparin Distribution Channels
Figure 50. Global Heparin Percentage 2016-2027: Indirect Sales VS Direct Sales
Figure 51. Global Heparin Percentage 2016-2027: Online Sales VS Offline Sales
Figure 52. Porter's Five Forces Analysis
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
  • Global Fibrinogen Concentrate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
  • Global Fibrinogen Concentrate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91
    According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
  • Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
  • Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
  • Global Low Molecular Weight Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
  • Global Heparin Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
  • Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
  • Global Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs